Nicholas Cappuccino
Nicholas Cappuccino
Chair, IGBA Science Committe
Chief Executive Officer and Principal Regulatory Consultant
Pharmaceutical Intellectual Resource Services LLC
Dr. Cappuccino currently serves as the Chair of the Science Committee for the International Generic and Biosimilar Medicines Association (IGBA) and represents IGBA on the ICH Management Committee and the ICH Assembly. Dr. Cappuccino is the Chief Executive Officer and Principal Regulatory Consultant of Pharmaceutical Intellectual Resource Services LLC, in Lambertville, NJ USA. Dr. Cappuccino has held the positions of Vice-President, Quality and Scientific Affairs, in Princeton NJ and Head of Global Quality for Dr. Reddy’s Laboratories Ltd., located in Hyderabad, India. Prior to these positions, Dr. Cappuccino was the Chief Scientific Officer of Eagle Pharmaceuticals Inc. in Woodcliff Lake, New Jersey, USA. Dr. Cappuccino was formerly the Executive Vice-President, Chief Scientific and Technical Officer of Andrx Pharmaceuticals and Watson Laboratories in Weston, Florida, USA. Prior to Andrx, Dr. Cappuccino was the Vice-President of Research and Development and a member of the Executive Management Committee for Sandoz Inc. in Princeton, NJ. Prior to joining Sandoz he was Vice-President of R&D for Apotex, Inc., Toronto, Canada, responsible for world-wide generic drug development at Apotex. He has also worked for Geneva Pharmaceuticals in Broomfield, Colorado, Hoechst-Roussel Pharmaceuticals, Bridgewater, NJ, and Schering-Plough Corporation in Bloomfield, NJ during his forty+ year career in the pharmaceutical industry.
Dr. Cappuccino holds a Ph.D. in Organic Chemistry from Stevens Institute of Technology, Hoboken, NJ, USA and an MBA from Fairleigh Dickinson University, Madison, NJ, USA.
